Prelude Therapeutics

Filed a patent for "smarca inhibitors 567 architectures" on Mon, August 21, 2023

Filed a patent for "mutant pi3k-alpha inhibitors and their use as pharmaceuticals" on Mon, April 3, 2023

Filed a patent for "treatment of recurrent high-grade glioma or uveal melanoma (um) using a protein arginine methyltransferase 5 (prmt5) brain-penetrant inhibitor" on Mon, May 15, 2023

Filed a patent for "cdk inhibitors and their use as pharmaceuticals" on Fri, April 14, 2023

Filed a patent for "cdk inhibitors and their use as pharmaceuticals" on Thu, October 24, 2024

Filed a patent for "crystalline forms of a cdk9 inhibitor and uses thereof" on Fri, April 12, 2024

Filed a patent for "cdk inhibitors and their use as pharmaceuticals" on Thu, July 25, 2024

Filed a patent for "brm targeting compounds and associated methods of use" on Fri, January 12, 2024

Filed a patent for "brm targeting compounds and associated methods of use" on Thu, September 15, 2022

Filed a patent for "cdk inhibitors and their use as pharmaceuticals" on Thu, May 11, 2023

Filed a patent for "treatment of cancers using combinations of smarca2 degraders and kras targeting therapies" on Mon, October 3, 2022

Filed a patent for "cdk inhibitors and their use as pharmaceuticals" on Thu, October 6, 2022

Filed a patent for "spiro-sulfonimidamide derivatives as inhibitors of myeloid cell leukemia-1 (mcl-1) protein" on Thu, July 6, 2023

Filed a patent for "mutant pi3k-alpha inhibitors and their use as pharmaceuticals" on Thu, October 20, 2022

Filed a patent for "brm targeting compounds and associated methods of use" on Tue, November 15, 2022

Filed a patent for "mutant pi3k-alpha inhibitors and their use as pharmaceuticals" on Wed, November 30, 2022

Filed a patent for "substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein arginine methyl transferase 5 (prmt5)" on Thu, June 8, 2023

Filed a patent for "cdk inhibitors and their use as pharmaceuticals" on Thu, July 27, 2023

Filed a patent for "cdk inhibitors and their use as pharmaceuticals" on Thu, August 17, 2023

Filed a patent for "heterocycle cdk inhibitors and their use thereof" on Thu, August 24, 2023

Filed a patent for "cdk inhibitors and their use as pharmaceuticals" on Thu, January 18, 2024

Filed a patent for "cdk inhibitors and their use as pharmaceuticals" on Thu, November 9, 2023

Filed a patent for "mutant pi3k-alpha inhibitors and their use as pharmaceuticals" on Thu, April 18, 2024

Filed a patent for "cdk inhibitors and their use as pharmaceuticals" on Thu, August 3, 2023

Filed a patent for "brm targeting compounds and associated methods of use" on Thu, November 16, 2023